China SXT Pharmaceuticals (SXTC) news

China SXT Pharmaceuticals - to effect 1-for-80 share consolidation effective August 10, 2026

Univest Securities, LLC announces closing of $9 million registered direct offering for its client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)

Univest Securities, LLC has announced the successful closing of a $9 million registered direct offering for its client, China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) [1]. The offering was conducted under the company’s existing at-the-market equity offering program and is intended to provide…

China SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals: $9M registered direct offering

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) has announced a registered direct offering of 66,666,666 Class A ordinary shares (or pre-funded warrants) at $0.15 per share, with aggregate gross proceeds expected to be approximately $10 million. The purchase price for pre-funded warrants equals the…

China SXT Pharmaceuticals: Files for offering of 157.5 mln class A ordinary shares by selling shareholder - SEC filing

China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) has announced a registered direct offering of 66,666,666 Class A ordinary shares at a price of $0.15 per share, with gross proceeds expected to total approximately $10 million. The transaction, which includes the option for pre-funded warrants in lieu…

China SXT Pharmaceuticals - to offer up to $100 mln of class A ordinary shares - SEC filing

China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) has announced plans to raise up to $10 million through the sale of 66,666,666 Class A ordinary shares in a registered direct offering at a price of $0.15 per share. The transaction, which includes the option to issue pre-funded warrants in lieu of…